Press releases

Filter by:

Filters
Reset

Capital increase a great success

€23m raised by full exercise of the extension clause Strong subscription from French and international institutional investors and individuals Offer subscribed 143% Evry (France) July 11, 2013 – Global Bioenergies…

Frédéric Pâques appointed as CTO

Evry June 10th, 2013 – Frédéric Pâques, former Scientific Director at Cellectis, joins Global Bioenergies (NYSE Alternext Paris: ALGBE) as Chief Technology Officer. Philippe Marlière, co-founder and President of Global…

Industrial pilot supported by a €5.2m State financing

This project, led by Global Bioenergies, brings together Arkema, two CNRS laboratories and the companies ARD and Processium Evry June 4th, 2013 – Global Bioenergies (NYSE Alternext Paris: ALGBE) announces…

RESULTATS DE L’EXERCICE CLOS AU 31 DECEMBRE 2012

Strong revenue growth Controlled increase of expenses Cash provides leeway in operations going forward Evry (France), April 24th, 2013 – Global Bioenergies (NYSE Alternext Paris: ALGBE), the industrial biology company…